In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Baxter buys Prism Pharmaceuticals for up to $338mm

Executive Summary

Baxter International Inc. has agreed to acquire closely held specialty pharma company Prism Pharmaceuticals Inc. for a total of $338mm, consisting of $170mm up front and $168mm in sales-based earn-outs.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Includes Earnout
    • Acquisition of Private Biotech

Related Companies